2002 to 2022 Saw Increased Use of Complementary Health by U.S. Adults
Significant increases seen across seven modalities for pain management
Price of Prescription Drugs Almost Threefold Higher in the United States
U.S. prices for brand-name originator drugs 422 percent higher; price of unbranded generics 67 percent of comparison countries
Sleep Quality and Energy Are Precursors of Incident Headache
Average stress and changes in subjective energy levels on previous day linked to incident headache, with different valence for timing of headache
Spinal Manipulation May Reduce Lumbar Spine Reoperations
Reoperations reduced for adults experiencing lumbosacral radiculopathy after lumbar discectomy with SMT versus usual care
2015 to 2021 Saw Increase in Gabapentinoid Use
Authors say increase driven by off-label uses for chronic pain with lack of evidence supporting use
Older Adults Average 20.7 Total Health Care Contact Days a Year
Factors linked to more ambulatory contact days include younger age, female sex, White race, non-Hispanic ethnicity
Improvements in Acute, Subacute Low Back Pain Seen Within First Six Weeks
Based on very low-certainty evidence, individuals with persistent low back pain have minimal improvements over time
>30 Percent With Migraine Experience Migraine-Related Stigma Often
Increased migraine-related stigma linked to increased disease burden across monthly headache day categories
Recent Reduction Seen in Opioid Prescribing by Surgeons
Decreasing trend seen in 81.6 percent of U.S. counties
FDA Says Marijuana Should Be Reclassified as Less Risky Drug
Currently, cannabis is classified as a Schedule I controlled substance, a category that includes heroin and LSD
